Around 39 percent of Carl Zeiss Meditec AG's shares are in free float. Approx. 59 percent are held by Carl Zeiss AG, one of the world's leading groups in the optical and optoelectronic industries. For further information visit: www.zeiss.com/med Video - https://mma.prnewswire.com/media/2755145/CIRRUS_PathFinder_Video.mp4 Logo - https://mma.prnewswire.com/media/546786/ZEISS_v1_Logo.jpg View original content: https://www.prnewswire.co.uk/news-releases/zeiss-announces-ce-mark-for-cirrus-pathfinder-ai-tool-with-automated-oct-assessment-302535575.html